Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-HER2 ANTIBODY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
Document Type and Number:
WIPO Patent Application WO/2022/196697
Kind Code:
A1
Abstract:
Provided is a non-cardiotoxic antibody drug for breast cancer treatment. The present invention relates to an anti-HER2 antibody, or a functional fragment thereof, that binds to HER2 expressed in breast cancer cells and does not bind to HER2 expressed in myocardial cells, and a pharmaceutical composition containing the same.

Inventors:
IRIMURA TATSURO (JP)
FUJIHIRA HARUHIKO (JP)
NAGAI DENDA KAORI (JP)
SAITO MITSUE (JP)
HORIMOTO YOSHIYA (JP)
SASAKI RITSUKO (JP)
NOJI MIKI (JP)
SUZUKI KAZUHIRO (JP)
AKATSUKA JUN-ICHI (JP)
ONO KEN-ICHIRO (JP)
NISHIDA SHIYO (JP)
MATSUURA KATSUHISA (JP)
SHIMIZU TATSUYA (JP)
Application Number:
PCT/JP2022/011687
Publication Date:
September 22, 2022
Filing Date:
March 15, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
JUNTENDO EDUCATIONAL FOUND (JP)
MEDICAL & BIOLOGICAL LABORATORIES CO LTD (JP)
International Classes:
C07K16/32; A61K38/05; A61K39/395; A61K47/68; A61P35/00; C12N15/13; C12P21/08
Foreign References:
JP2009529010A2009-08-13
Other References:
DUARTE HENRIQUE, BALMAÑA MERITXELL, MEREITER STEFAN, OSÓRIO HUGO, GOMES JOANA, REIS CELSO: "Gastric Cancer Cell Glycosylation as a Modulator of the ErbB2 Oncogenic Receptor", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 18, no. 11, pages 2262, XP055967536, DOI: 10.3390/ijms18112262
KIT OLEG I., FRANTSIYANTS ELENA M., DJENKOVA LUBOV A., KATELNITSKAYA OKSANA V., SHIKHLYAROVA ALLA I., SAGAKYANTS ALEKSANDR B., VER: "Cardiotoxicity: a challenge for modern oncology", CARDIOMETRY, vol. 13814, no. 13, 1 November 2018 (2018-11-01), XP055967534, DOI: 10.12710/cardiometry.2018.13.814
Attorney, Agent or Firm:
THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)
Download PDF: